Google News – Pharmaceuticals External News
Regulatory & Compliance Articles
Google News – Pharmaceuticals External News
Quoin Pharmaceuticals Announces FDA Grants Rare Pediatric Disease Designation for QRX003 in Peeling Skin Syndrome - The Manila Times
Google News – FDA (biotech/pharma) External News
Project Optimus explained: what the FDA expects on oncology dosing - The Pharma Letter
Google News – Clinical Trials External News
Intellia Therapeutics Announces FDA Acceptance of Biologics License Application with Priority Review for Lonvoguran Ziclumeran (Lonvo-z) for Hereditary Angioedema (HAE) - Intellia Therapeutics
Google News – Pharmaceuticals External News
X4 Pharmaceuticals: FDA OKs Reduced Sample Size for 4WARD Phase 3, Enrollment to Finish by Year-End 2026 - TradingView
Google News – FDA (biotech/pharma) External News
FDA backs smaller late-stage test of X4 (NASDAQ: XFOR) neutropenia drug, with pivotal data not due until 2028 - Stock Titan
Google News – Pharmaceuticals External News
Kiora Pharmaceuticals Appoints Keith J. Lane as Executive Vice President of Global Clinical Development and Regulatory Affairs - TMX Newsfile
Google News – Pharmaceuticals External News
X4 Pharmaceuticals Announces Positive Outcome from FDA Type C Meeting - GlobeNewswire
Google News – Pharmaceuticals External News
The FDA agreed to a 126-person trial for a rare blood condition. Topline data is expected in the first half of 2028. - Stock Titan
Industry News External News
HSA warns of banned substance, potent medicinal ingredients in product marketed as weight-loss pill - The Straits Times
Google News – FDA (biotech/pharma) External News
Biotech filed for bankruptcy 11 weeks before its big FDA decision - thestreet.com
Google News – Pharmaceuticals External News
Learn Why The Bull Case For Jazz Pharmaceuticals Stock Could Change Following FDA Drug Approval - simplywall.st
Google News – FDA (biotech/pharma) External News
Tukaram Mundhe acts against 880 Maharashtra pharma units, Rs 11-crore stock seized - India Today
Google News – Pharmaceuticals External News
Ionis Pharmaceuticals, Inc. (IONS) Discusses FDA Approval and Launch Strategy for ZANVASTRO in Alexander Disease - Slideshow (NASDAQ:IONS) 2026-09-07 - Seeking Alpha
Google News – Medical Devices External News

